The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,134.00
Bid: 12,134.00
Ask: 12,136.00
Change: -162.00 (-1.32%)
Spread: 2.00 (0.016%)
Open: 12,226.00
High: 12,266.00
Low: 12,068.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-UK's Johnson looks for path out of lockdown after 15 million vaccinated

Mon, 15th Feb 2021 07:43

* UK hits 15 million vaccination target

* UK PM Johnson to judge this week on lockdown exit

* UK looking at vaccine certificates to help Britons travel

* Hotel quarantine is going smoothly, minister says
(Adds calls for lockdown to end)

By Guy Faulconbridge and Kate Holton

LONDON, Feb 15 (Reuters) - British Prime Minister Boris
Johnson will judge this week how fast England can exit COVID-19
lockdown after vaccinating 15 million of its most vulnerable
people, but the health minister said death and hospital
admission numbers were still too high.

With nearly a quarter of the United Kingdom's population now
inoculated with a first dose of a COVID vaccine in a little over
two months, Johnson is under pressure from some lawmakers and
businesses to reopen the shuttered economy.

"We've got to watch the data," Health Secretary Matt Hancock
told Sky News. "Everybody wants to get out of this as quickly as
we safely can, and both as quickly, but also as safely, are
important.

"The question is a judgment of how quickly and safely, how
quickly we can do that safely. That's the judgment that we're
making this week, looking at the data, ahead of the prime
minister setting out the roadmap, on the 22nd," he said.

The biggest and swiftest global vaccine rollout in history
is seen as the best chance of exiting the COVID-19 pandemic
which has killed 2.4 million people, tipped the global economy
into its worst peacetime slump since the Great Depression and
upended normal life for billions.

Britain has vaccinated 15.062 million people with a first
dose and 537,715 with a second dose, the fastest rollout per
capita of any large country. Hancock said he expected vaccine
supplies to increase as manufacturing accelerated.

An influential group of lawmakers in Johnson's Conservative
Party are calling for the end of lockdown as soon as the most
vulnerable nine groups are vaccinated. They want no more rules
beyond May 1.

"We're all filled with sorrow for the people we've lost, the
harms that we've suffered but we don't honour those we've loved
and lost by wrecking the rest of our lives," lawmaker Steve
Baker said. "We've got to find a way to rebuild our society and
our economy and our prospects, our livelihoods."

Hancock said the British government was speaking to other
countries across the world about giving British people
certificates showing they had been vaccinated so that they could
travel abroad in the future to countries that require them.

"There is this international work going on because if other
countries require (proof of vaccination) we want to allow Brits
to be able to travel to those countries," Hancock said.

"We'd want to be able to facilitate that sort of vaccine
certification, but it isn't anything we're planning to introduce
here," he said, adding that a so-called vaccine passport was not
something that would be required to access services in the UK.

The United Kingdom has the world's fifth-worst official
death toll - currently 117,166 - after the United States,
Brazil, Mexico and India.

A new COVID-19 hotel quarantine system for arrivals from 33
"red list" countries, intended to limit the spread of new
variants of the virus, appeared to be working smoothly a few
hours after it was introduced, Hancock said.
(Reporting by Guy Faulconbridge and Kate Holton; Editing by
James Davey, Peter Graff and Nick Macfie)

More News
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.